Thursday, July 30, 2020

Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing

Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Data center tenants now demand $5M+ a day in late-delivery fees, up from $1M this spring, spawning new "delay-in-delivery" coverage from brokers like Marsh (Ann Davis Vaughan/The Information)

Ann Davis Vaughan / The Information : Data center tenants now demand $5M+ a day in late-delivery fees, up from $1M this spring, spawning ...